SCHEMBL2084233

SCHEMBL2084233

Cc1cccnc1CC(CCCN)NCc1ncccc1C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 8/20 0.42
CD38 P28907 1/20 0.39
ADORA2A P29274 2/20 0.34
DHODH Q02127 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
SSTR4 P31391 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
SCN8A Q9UQD0 1/20 0.32
HSD17B13 Q7Z5P4 1/20 0.31
ADORA1 P30542 1/20 0.31
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HTR2B P41595 1/20 0.30
P2RX7 Q99572 1/20 0.30
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM5 P08912 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4214955 0.88 CXCR4 (0.41) CXCR4ADORA2AMAOAMAOBADORA1
SCHEMBL2085140 0.85 AGBL2 (0.36) CXCR4ADORA2AMAOAMAOBADORA1
SCHEMBL2083105 0.85 CACNA1H (0.35) CXCR4ADORA2ASSTR4MAOAMAOB
SCHEMBL2082171 0.84 ADORA2A (0.41) CXCR4ADORA2AMAOAMAOBADORA1
SCHEMBL2083908 0.81 ADORA2A (0.38) CXCR4ADORA2AMAOAMAOBADORA1
SCHEMBL2085159 0.81 CXCR4 (0.38) CXCR4ADORA2AMAOAMAOBADORA1
SCHEMBL2084154 0.79 ADORA2A (0.37) CXCR4ADORA2AADORA1
SCHEMBL2083555 0.79 CXCR4 (0.39) CXCR4ADORA2AMAOAMAOBADORA1
SCHEMBL2084496 0.78 CXCR4 (0.38) CXCR4
SCHEMBL2084803 0.77 SYK (0.35) CXCR4ADORA2AMAOAMAOBADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863293-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2011-01-04 US claimed
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED CORPORATION (CA) 2008-10-16 US claimed
US-7291631-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2007-11-06 US claimed
US-7863293-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2011-01-04 US disclosed
EP-1613613-A4 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2009-03-25 EP disclosed
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED CORPORATION (CA) 2008-10-16 US disclosed
US-7291631-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2007-11-06 US disclosed
EP-1613613-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-01-11 EP disclosed
WO-2004091518-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2004-10-28 WO disclosed
US-20040209921-A1 CXCR4 chemokine receptor binding comounds ANORMED CORPORATION (CA) 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209921-A1 CXCR4 chemokine receptor binding comounds CXCR4, CXCR1, CXCR3 CXCR4 1/4885CD38 48/4885ADORA2A 66/4885
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS CXCR4, CXCR1, CXCR3 CXCR4 1/4885CD38 36/4885ADORA2A 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.